Herbs (Global Traditional) · European
Arnica (Arnica montana) (Arnica montana)
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Arnica montana contains sesquiterpene lactones and flavonoids that exhibit anti-inflammatory properties through inhibition of nuclear factor-kappa B (NF-κB) pathways. The plant demonstrates preliminary antioxidant activity in laboratory studies, though clinical evidence for human health benefits remains limited.
Arnica montana is a perennial herbaceous plant native to European mountains, belonging to the Asteraceae family, with dried flower heads serving as the primary medicinal component. The flowers are processed through various extraction methods including ethanolic extraction (70% ethanol, 1:15 ratio), supercritical CO2 extraction (40°C, 16 MPa), and steam distillation to produce tinctures, extracts, and essential oils.
No human clinical trials, RCTs, or meta-analyses with PubMed PMIDs were identified in the available research. Current studies focus exclusively on extraction methodology optimization and in vitro antioxidant activity assessments rather than clinical efficacy.
Standard tinctures are prepared at 1:10 (drug:ethanol 60-70% V/V) or 1:5 (ethanol 60% V/V), and liquid extracts at 1:20, though no clinically studied therapeutic dosage ranges are established. Consult a healthcare provider before starting any new supplement.
Arnica montana is a medicinal herb not intended for nutritional/dietary consumption due to toxicity when ingested; its profile is characterized by bioactive compounds rather than conventional macronutrients. Key bioactive constituents include: sesquiterpene lactones (0.3–1.0% dry weight), primarily helenalin and dihydrohelenalin and their ester derivatives, which are the principal pharmacologically active compounds. Flavonoids present at approximately 0.4–0.6% dry weight, including quercetin, luteolin, kaempferol, and their glycosides (patuletin, spinacetin). Phenolic acids include chlorogenic acid and caffeic acid derivatives at roughly 0.15–0.3% dry weight. Essential oil content ranges from 0.2–0.35% and contains thymol, thymol methyl ether, and various monoterpenes and sesquiterpenes. Carotenoids (notably beta-carotene and lutein) are present in flower heads at trace concentrations (~50–100 µg/g dry weight). Polysaccharides including inulin-type fructans occur in roots at 1–2% dry weight. Tannins contribute approximately 0.5–1.0% dry weight. Coumarins (scopoletin, umbelliferone) are present at trace levels (<0.1%). Cynarin (a caffeoylquinic acid derivative) has been identified in leaf fractions. Total phenolic content measured via Folin-Ciocalteu in ethanolic flower extracts ranges from 15–40 mg gallic acid equivalents per gram dry weight. Bioavailability of helenalin via topical application is documented; oral ingestion is contraindicated due to hepatotoxicity and mucosal irritation at concentrations above trace levels. Conventional macronutrients (protein, fat, carbohydrates as food energy) are not applicable given its non-food status.
Arnica's sesquiterpene lactones, particularly helenalin and 11α,13-dihydrohelenalin, inhibit nuclear factor-kappa B (NF-κB) transcription factor, reducing inflammatory cytokine production. Flavonoids including quercetin and kaempferol contribute to antioxidant activity by scavenging free radicals and chelating metal ions. These compounds may also modulate cyclooxygenase and lipoxygenase enzyme activity, potentially reducing prostaglandin synthesis.
Current clinical evidence for arnica remains limited, with most research focusing on extraction optimization rather than human health outcomes. In vitro studies demonstrate antioxidant activity through DPPH radical scavenging assays, but these laboratory findings require validation in human trials. Traditional European topical applications lack robust clinical verification. No large-scale randomized controlled trials have established definitive therapeutic benefits or optimal dosing protocols for arnica supplementation.
Topical arnica applications may cause contact dermatitis, especially in individuals sensitive to Asteraceae family plants. Oral consumption of arnica can lead to gastrointestinal irritation, dizziness, and cardiac arrhythmias due to sesquiterpene lactone content. Arnica may interact with anticoagulant medications by potentially enhancing bleeding risk. Pregnant and breastfeeding women should avoid arnica due to insufficient safety data and potential uterine stimulant effects.
